These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 2172983

  • 1. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.
    Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL.
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8331-5. PubMed ID: 2172983
    [Abstract] [Full Text] [Related]

  • 2. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.
    Himmler A, Maurer-Fogy I, Krönke M, Scheurich P, Pfizenmaier K, Lantz M, Olsson I, Hauptmann R, Stratowa C, Adolf GR.
    DNA Cell Biol; 1990 Dec; 9(10):705-15. PubMed ID: 1702293
    [Abstract] [Full Text] [Related]

  • 3. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.
    Nophar Y, Kemper O, Brakebusch C, Englemann H, Zwang R, Aderka D, Holtmann H, Wallach D.
    EMBO J; 1990 Oct; 9(10):3269-78. PubMed ID: 1698610
    [Abstract] [Full Text] [Related]

  • 4. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein.
    Gray PW, Barrett K, Chantry D, Turner M, Feldmann M.
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7380-4. PubMed ID: 2170974
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors.
    Higuchi M, Aggarwal BB.
    Biochem Biophys Res Commun; 1992 Jan 31; 182(2):638-43. PubMed ID: 1310388
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.
    Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W.
    Cell; 1990 Apr 20; 61(2):351-9. PubMed ID: 2158862
    [Abstract] [Full Text] [Related]

  • 7. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.
    Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV.
    Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2830-4. PubMed ID: 1849278
    [Abstract] [Full Text] [Related]

  • 8. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ, Trinh H, Nedelman M, Brennan FM, Feldmann M, Ghrayeb J.
    Cytokine; 1995 Nov 01; 7(8):759-70. PubMed ID: 8664442
    [Abstract] [Full Text] [Related]

  • 9. Molecular cloning and expression of a receptor for human tumor necrosis factor.
    Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H.
    Cell; 1990 Apr 20; 61(2):361-70. PubMed ID: 2158863
    [Abstract] [Full Text] [Related]

  • 10. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.
    Pennica D, Lam VT, Weber RF, Kohr WJ, Basa LJ, Spellman MW, Ashkenazi A, Shire SJ, Goeddel DV.
    Biochemistry; 1993 Mar 30; 32(12):3131-8. PubMed ID: 8384489
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the effects of tumor necrosis factor inhibitors on human hematopoiesis.
    Ferrajoli A, Talpaz M, Kurzrock R, Estrov Z.
    Stem Cells; 1993 Mar 30; 11(2):112-9. PubMed ID: 8384506
    [Abstract] [Full Text] [Related]

  • 12. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
    Gatanaga T, Hwang CD, Kohr W, Cappuccini F, Lucci JA, Jeffes EW, Lentz R, Tomich J, Yamamoto RS, Granger GA.
    Proc Natl Acad Sci U S A; 1990 Nov 30; 87(22):8781-4. PubMed ID: 2174164
    [Abstract] [Full Text] [Related]

  • 13. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M, Simoni P, Antonetti F.
    J Interferon Cytokine Res; 1996 Dec 30; 16(12):1047-53. PubMed ID: 8974008
    [Abstract] [Full Text] [Related]

  • 14. A tumor necrosis factor decoy receptor homologue is up-regulated in the brook trout (Salvelinus fontinalis) ovary at the completion of ovulation.
    Bobe J, Goetz FW.
    Biol Reprod; 2000 Feb 30; 62(2):420-6. PubMed ID: 10642582
    [Abstract] [Full Text] [Related]

  • 15. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor.
    Smith CA, Davis T, Wignall JM, Din WS, Farrah T, Upton C, McFadden G, Goodwin RG.
    Biochem Biophys Res Commun; 1991 Apr 15; 176(1):335-42. PubMed ID: 1850261
    [Abstract] [Full Text] [Related]

  • 16. A secreted high-affinity inhibitor of human TNF from Tanapox virus.
    Brunetti CR, Paulose-Murphy M, Singh R, Qin J, Barrett JW, Tardivel A, Schneider P, Essani K, McFadden G.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4831-6. PubMed ID: 12676996
    [Abstract] [Full Text] [Related]

  • 17. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.
    Heller RA, Song K, Onasch MA, Fischer WH, Chang D, Ringold GM.
    Proc Natl Acad Sci U S A; 1990 Aug 15; 87(16):6151-5. PubMed ID: 2166946
    [Abstract] [Full Text] [Related]

  • 18. Mapping the lectin-like activity of tumor necrosis factor.
    Lucas R, Magez S, De Leys R, Fransen L, Scheerlinck JP, Rampelberg M, Sablon E, De Baetselier P.
    Science; 1994 Feb 11; 263(5148):814-7. PubMed ID: 8303299
    [Abstract] [Full Text] [Related]

  • 19. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH.
    Proc Natl Acad Sci U S A; 1991 Dec 01; 88(23):10535-9. PubMed ID: 1660140
    [Abstract] [Full Text] [Related]

  • 20. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE, Scallon BJ, Trinh H, Chernajovsky Y, Ghrayeb J, Feldmann M.
    Eur Cytokine Netw; 1998 Sep 01; 9(3):255-62. PubMed ID: 9831174
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.